Dao-bin Zhou
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 71
- Multiple Myeloma Research and Treatments 49
-
- Lymphoma Diagnosis and Treatment 59
- Co-authors
- Jian Li (125 shared papers)Xin-xin Cao (135 shared papers)Minghui Duan (67 shared papers)Lu Zhang (43 shared papers)Hao Cai (38 shared papers)Wei Zhang (58 shared papers)Zhang Yan (60 shared papers)Jian Hua Sun (23 shared papers)
- Journals
- Annals of Hematology (36 papers)Blood (19 papers)Leukemia Research (12 papers)Orphanet Journal of Rare Diseases (11 papers)Frontiers in Oncology (8 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dao-bin Zhou
312 papers receiving 4.8k citations
Dao-bin Zhou's Hit Papers
Peers
Comparison fields: 5 of 77
- Hematology 1.3k
- Pathology and Forensic Medicine 591
- Genetics 311
- Oncology 432
- Neurology 249
Countries citing papers authored by Dao-bin Zhou
This map shows the geographic impact of Dao-bin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dao-bin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dao-bin Zhou more than expected).
Fields of papers citing papers by Dao-bin Zhou
This network shows the impact of papers produced by Dao-bin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dao-bin Zhou. The network helps show where Dao-bin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Dao-bin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 338 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma Hit paper breakdown → | 2015 | 311 |
| 2 | 2018 | 237 | |
| 3 | 2017 | 203 | |
| 4 | The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update Hit paper breakdown → | 2021 | 197 |
| 5 | 2011 | 125 | |
| 6 | 2011 | 111 | |
| 7 | 2020 | 109 | |
| 8 | 2016 | 87 | |
| 9 | 2020 | 86 | |
| 10 | 2011 | 83 | |
| 11 | 2013 | 66 | |
| 12 | 2019 | 59 | |
| 13 | 2018 | 58 | |
| 14 | 2012 | 53 | |
| 15 | 2017 | 53 | |
| 16 | 2023 | 51 | |
| 17 | 2024 | 48 | |
| 18 | 2021 | 47 | |
| 19 | 2018 | 44 | |
| 20 | 2019 | 44 |
About Dao-bin Zhou
Dao-bin Zhou is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Physiology and Oncology, having authored 338 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (59 papers), Multiple Myeloma Research and Treatments (49 papers), Histiocytic Disorders and Treatments (34 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (26 papers), Chronic Lymphocytic Leukemia Research (18 papers), CNS Lymphoma Diagnosis and Treatment (16 papers), CAR-T cell therapy research (12 papers) and Viral-associated cancers and disorders (9 papers). The work is most often cited by research in Hematology (1.3k citations), Pathology and Forensic Medicine (591 citations), Genetics (311 citations), Oncology (432 citations) and Neurology (249 citations). Dao-bin Zhou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jian Li, Xin-xin Cao, Minghui Duan, Lu Zhang, Hao Cai, Wei Zhang, Zhang Yan, Jian Hua Sun, Jun Feng and Kaini Shen. Their work appears in journals such as Annals of Hematology, Blood, Leukemia Research, Orphanet Journal of Rare Diseases and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.